Nimodipine Reappraised: An Old Drug with a Future
Sign Up to like & getrecommendations! Published in 2019 at "Current Neuropharmacology"
DOI: 10.2174/1570159x17666190927113021
Abstract: Nimodipine is a dihydropyridine calcium channel antagonist that blocks the flux of extracellular calcium through L-type, voltage-gated calcium channels. While nimodipine is FDA-approved for the prevention and treatment of neurological deficits in patients with aneurysmal… read more here.
Keywords: drug; old drug; nimodipine; nimodipine reappraised ... See more keywords